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SUMMARY
The use of Cre-driver rodent lines for targeting ventral tegmental area (VTA) cell types has 
generated important and novel insights into how precise neurocircuits regulate physiology and 
behavior. While this approach generally results in enhanced cellular specificity, an important issue 
has recently emerged related to the selectivity and penetrance of viral targeting of VTA neurons 
using several Cre-driver transgenic mouse lines. Here, we highlight several considerations when 
utilizing these tools to study the function of genetically defined neurocircuits. While VTA 
dopaminergic neurons have previously been targeted and defined by the expression of single genes 
important for aspects of dopamine neurotransmission, many VTA and neighboring cells display 
dynamic gene expression phenotypes that are partially consistent with both classically described 
dopaminergic and non-dopaminergic neurons. Thus, in addition to varying degrees of selectivity 
and penetrance, distinct Cre lines likely permit targeting of partially overlapping, but not identical 
VTA cell populations.
Accurately defining and studying the function of distinct neural subtypes and circuits 
represents one of the major challenges in neuroscience today. Cell types can be defined by a 
variety of means such as anatomical location, afferent and efferent connectivity, 
electrophysiological properties, behavioral functions, or by their molecular characteristic 
such as their gene expression profiles. Given the intense heterogeneity of nervous system 
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tissue, many recent studies have utilized genetic tools, such as rodent lines, that express Cre-
recombinase under selected gene promoters (Gerfen et al., 2013; Taniguchi et al., 2011; 
Witten et al., 2011) in order to selectively monitor or manipulate neuronal subpopulations. 
Furthermore, genetically defined neurons that express Cre-recombinase can reliably be 
targeted for optogenetic or chemogenetic manipulation in anatomically defined brain regions 
in adult animals by utilizing cre-inducible viral constructs (Atasoy et al., 2008; Sohal et al., 
2009) that are stereotaxically delivered to the brain region of interest. Overall, this combined 
approach has generated tremendous insight into the organization and function of genetically 
defined neural circuits. These tools have widely been adopted and are now commonly used 
throughout many distinct subfields of neuroscience. Below we discuss some important 
aspects related to the use of these approaches within the context of the ventral tegmental 
area (VTA), a heterogeneous brain region critical for motivated behavior.
The VTA contains many distinct cell types, the two largest classically described populations 
being dopaminergic and GABAergic neurons that are largely intermixed. A smaller 
population of VTA glutamatergic neurons has also been identified (Yamaguchi et al., 2007, 
2011). VTA dopaminergic neurons have been targeted for manipulation by utilizing mouse 
lines that express Cre recombinase under the control of gene promoters thought to define a 
dopaminergic phenotype. The two most commonly used lines drive expression under the 
tyrosine hydroxylase promoter (TH-Cre; (Lindeberg et al., 2004; Savitt et al., 2005) or the 
dopamine transporter promoter (DAT-Cre; (Bäckman et al., 2006; Zhuang et al., 2005)). 
While these are excellent genetic tools to gain further insight into VTA circuits, the presence 
of a single gene, such as TH or DAT, alone within a neuron contributes to, but does not 
solely define its phenotype. Consistent with this, dopaminergic neurons have previously 
been shown to be quite heterogeneous with respect to their projection targets, gene 
expression profiles, and physiological properties (Lammel et al., 2008; Margolis et al., 2006, 
2008).
Lammel et al., report that TH-Cre or GFP mouse lines display ectopic targeting of non-
dopaminergic VTA neurons. Below we highlight important conceptual and technical caveats 
for the use of Cre driver lines to target VTA circuitry. In addition, we discuss the idea that 
individual neurons are more accurately described by a phenotypic spectrum as opposed to a 
digital classification system, especially when defining cell populations based on the 
expression patterns of single genes. This is largely based on evidence that individual VTA 
cells can co-express genes or immunostain for markers associated with the biosynthesis of 
multiple neurotransmitters, and that the expression levels of TH and DAT can vary 
dramatically across individual VTA neurons or animal strain, suggesting that TH-Cre and 
DAT-Cre transgenic mouse lines label partially overlapping, but not identical midbrain cell 
populations.
Response to the Lammel et al paper
Lammel et al. report that many midbrain cells targeted in TH-Cre or TH-GFP lines are not 
TH-positive and that targeted neurons are located outside of the VTA/SNc. They conclude 
that appreciable ectopic expression exists in these TH-driven transgenic lines, but not in the 
DAT-cre mouse line that was also tested. In addition, they conclude that VTA neurons that 
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project to the lateral habenula (LHb) are largely GABAergic. Based on the data and 
conclusions presented in their paper, there are three points that we think merit further 
discussion.
1) Selectivity and penetrance of transgene expression in TH-Cre lines and DAT-Cre mouse 
lines
Lammel et al., report that following Cre-inducible virus injection into the VTA of TH-Cre or 
DAT-Cre mice, there is appreciable viral-mediated expression in both TH positive and TH 
negative neurons in and around the VTA in the TH-Cre line, while viral expression is 
restricted to VTA TH positive neurons in the DAT-Cre line. In addition, in the lateral VTA 
there is high co-localization between TH and targeted neurons in the TH-Cre line, but co-
localization is significantly less in the medial VTA in this line. These results may be due to 
ectopic cre expression in the medial VTA in the TH-Cre lines (cre expression in cells that 
are TH negative) or due to sufficient cre expression in neurons only weakly expressing TH 
mRNA or protein. Consistent with the latter, TH expression and immunofluorescence can 
vary widely from cell-to-cell and along the medial-lateral axis (Harris and Nestler, 1996; 
Weiss-Wunder and Chesselet, 1991, Fig. 1), and thus it is possible that immunofluorescent 
staining may not reliably label neurons that produce low levels of TH protein. This may be 
less of an issue with the DAT-Cre mouse line since DAT is enriched in cells that also 
express high levels of TH (Lammel et al., 2008; Stamatakis et al., 2013). It is important to 
note that Cre-mediated recombination can likely occur in cells with even weakly active 
promoters and thus low levels of Cre, since virally mediated Cre-inducible transgene 
expression is decoupled from the levels of expression at the endogenous genetic locus 
(Atasoy et al., 2008; Sohal et al., 2009). Moreover, it is unclear whether viral titre or 
injection volume may also influence targeted cell selectivity since Cre-inducible expression 
systems likely depends not only on the amount of Cre present in a cell, but also on the 
number of virally delivered transgenes that undergo recombination. Therefore, the 
discrepancy between the percentage of overlap between eYFP+ and TH+ neurons reported 
in Lammel et al. and previous studies (Chaudhury et al., 2013; Stamatakis et al., 2013; Tsai 
et al., 2009; Tye et al., 2013) could be due to differences in immunohistochemical 
techniques and confocal imaging parameters in addition to the quantification of particular 
VTA subregions as they discussed.
In wild type animals TH positive neurons are also distributed in areas surrounding the 
VTA/SNc including the retrorubral field and periaquaductal gray (Nair-Roberts et al., 2008), 
and to a lesser extent, the substantia nigra pars reticulata (Stork et al., 1994). In fact, the A10 
dopaminergic cell group has been previously described to contain a dense extension of TH 
positive neurons that reside in the tuberomamillary nucleus and the medial supramammiliary 
region (Swanson, 1982). Therefore, it is not particularly surprising that Lammel et al. report 
the presence eYFP+ neurons in areas surrounding the VTA in the TH-Cre line, especially 
considering the large volumes of virus injected in their study. In contrast, DAT expression is 
largely restricted to TH positive neurons in VTA/Sn, but does not co-localize completely 
with TH positive neurons in the VTA (Blanchard et al., 1995; Li et al., 2013). Thus, it is 
likely that DAT-Cre and TH-Cre mouse lines permit targeting of overlapping, but not 
identical, populations of VTA neurons. The TH-Cre lines thus may display reduced 
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selectivity for dopaminergic neurons (as defined by expressing high levels of both TH and 
DAT protein), especially in the medial VTA compared to the DAT-Cre line as reported by 
Lammel et al. However, the DAT-Cre line may have reduced penetrance for targeting 
dopaminergic neurons compared to the TH-Cre lines as non-striatal projecting TH+ VTA 
cells display reduced levels of DAT compared to nucleus accumbens projecting cells 
(Lammel et al., 2008). Both selectivity and penetrance of transgene expression are important 
factors to consider, and should be evaluated collectively based on the purpose of the 
experiment.
2) Cellular Phenotype of LHb projecting VTA neurons
In the manuscript by Lammel et al., they report that LHb projecting VTA neurons are 
GABAergic or glutamatergic, and that these LHb projections act to inhibit or excite LHb 
postsynaptic neurons respectively, which in turn promotes reward or aversive-related 
behavior. These results are consistent with our previous work (Stamatakis et al., 2013) as 
well the work of others (Hnasko et al., 2012; Root et al., 2014a, 2014b). Moreover, In our 
previous paper (Stamatakis et al., 2013) we reported that virally targeting of VTA neurons in 
the TH-Cre line resulted in labeled fibers in the LHb that release GABA to inhibit LHb 
neurons to promote reward. In addition, retrograde labeling of LHb projecting VTA neurons 
in mice and rats demonstrates that this projection arises from a mixture of TH positive and 
TH negative VTA neurons (Gruber et al., 2007; Skagerberg et al., 1984; Stamatakis et al., 
2013; Swanson, 1982). Additionally, in situ hybridization experiments revealed that over 
20% of LHb projecting VTA neurons co-express TH, GAD, and VGlut2 (Root et al., 2014b). 
Thus, LHb projecting VTA neurons are genetically diverse and express markers consistent 
with multiple neurotransmitter systems, which likely regulates the functionality of this 
circuit.
We have previously referred to LHb projecting VTA neurons as having a hybrid phenotype, 
which is consistent with gene expression data from these cells (Root et al., 2014b). 
However, as we previously demonstrated (and was confirmed by Lammel et al.) the targeted 
VTA-to-LHb projection in the TH-Cre line is largely functionally GABAergic and acts to 
inhibit LHb neurons. Interestingly, while Lammel et al. did not observe significant eYFP 
fibers in the LHb from the DAT-Cre mice, we observed appreciable eYFP fibers in this line 
following virus injection in the VTA (Fig. 2). We also observed a qualitatively different 
expression pattern from Vgat-Cre mice (Fig. 2). Collectively, these data (as well as work by 
Morales and colleagues (Root et al., 2014a, 2014b), demonstrate that LHb-projecting VTA 
neurons are genetically heterogeneous, and cannot be simply classified as strictly 
dopaminergic, GABAergic or glutamatergic based on single genetic markers as proposed by 
Lammel et al. Instead, we argue that the most accurate description of VTA neurons that 
project to the LHb would be a mixture of both functional GABAergic and glutamatergic 
neurons, some of which also express genetic markers for dopaminergic neurons. This 
assessment is based on experiments conducted in both wild type and transgenic animals and 
is not dependent on any single Cre driver line.
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3) Electrophysiological properties of LHb projecting VTA neurons
Lammel et al. recorded from eYFP+/TH+ and eYFP+/TH− VTA neurons in the TH-Cre line 
(which may have low to no TH expression and protein, as discussed above) and report that 
eYFP+/TH− neurons have electrophysiological characteristics that are similar to 
GABAergic neurons and thus these cells are likely ectopically labeled GABAergic neurons 
and not dopaminergic neurons. However, the electrophysiological phenotype of these 
neurons is also consistent with medial dopaminergic neurons that show electrophysiological 
properties similar to GABAergic neurons. Indeed, Lammel and colleagues have previously 
reported that cortical-projecting dopaminergic neurons, which are enriched in the medial 
VTA, show elevated basal firing rates, narrow action potentials, lack functional D2 
autoreceptors, and lack of an inward hyperpolarizing current (Lammel et al., 2008). Thus the 
electrophysiological phenotypes of VTA neurons may be more related to their projection 
target and location within the VTA, than whether they immunostain for TH.
Co-localization and heterogeneity of dopaminergic, glutamatergic, and GABAergic cell 
markers within VTA neurons: Implications for utilizing single-gene Cre driver lines to 
study neurocircuitry
As discussed above, some VTA neurons express markers consistent with the synthesis and 
release of multiple small molecule neurotransmitters. For example up to 20% of VTA TH 
positive neurons also express the gene coding for the vesicular glutamate transporter 2 
(VGLUT2), a marker for putative glutamatergic neurons (Hnasko et al., 2010, 2012; 
Kawano et al., 2006; Li et al., 2013; Mendez et al., 2008; Root et al., 2014b; Yamaguchi et 
al., 2011) Consistent with this, optical stimulation of dopaminergic fibers that innervate 
striatal subregions results in the release of dopamine, glutamate, and GABA (Stuber et al., 
2010; Tecuapetla et al., 2010; Tritsch et al., 2012). Thus, there is evidence in the literature 
that previously defined midbrain dopaminergic neurons can express genes and display 
physiological properties that are consistent with multiple modalities of neurotransmission. 
Furthermore, there is emerging evidence that some individual midbrain neurons may express 
dopaminergic and GABAergic gene markers (Root et al., 2014b). In the lateral VTA and 
substantia nigra pars compacta (SNc) TH expressing neurons and those that express of the 
GABA synthetic enzymes (GAD65 and GAD67) are almost completely segregated (Nair-
Roberts et al., 2008; Tritsch et al., 2014; Fig. 3). However, in the anterior medial VTA and 
surrounding areas including the tuberomamillary nucleus, TH or DAT and GAD are co-
expressed in a number of cells ((Olson and Nestler, 2007; Root et al., 2014b; Tritsch et al., 
2014; Fig. 3). Finally, a recent study has demonstrated that the majority of LHb-projecting 
VTA neurons, some of which express TH, release both glutamate and GABA (Root et al., 
2014b). Collectively, these emerging findings suggest that single gene marker such as TH, 
DAT, VGLUT2, or GAD65/67 cannot fully define the molecular phenotype of VTA 
neuronal subpopulations. This is especially important to consider when targeting VTA 
circuitry with a rodent line that expresses Cre under the control of a single gene promoter.
Additional considerations and future directions
Accurately defining and manipulating exact cellular phenotypes in the nervous system 
requires comprehensive information on the connectivity, physiological function, anatomical 
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location, and genetic landscape of numerous individual neurons sampled from a larger 
population. Applying automated and non-biased cluster analysis approaches to these 
integrated, but diverse datasets may uncover more specific cellular phenotypes. Future 
studies that implement these approaches promise to provide a more accurate definition of the 
cellular diversity within the VTA and other brain structures, and also permit for the 
implementation of intersectional genetic approaches (Dymecki et al., 2010; Robertson et al., 
2013) for targeted manipulation of cell types based on combinatorial gene expression 
patterns (Fenno et al., 2014). Finally, it is important to consider that neuronal phenotypes are 
likely dynamically regulated and not static. Developmental, environmental, activity-
dependent, and epigenetic regulation likely produce pronounced alterations in neuronal 
phenotypes and neurocircuit function (Andersson et al., 2006; Dulcis et al., 2013; Gómez-
Lira et al., 2005; Guemez-Gamboa et al., 2014; Matsushita et al., 2002; Stott et al., 2013; 
Telese et al., 2013). Genetically informed neuronal targeting strategies continue to generate 
new insights. Corroborating these findings with a multifaceted approach will provide a more 
holistic understanding of the functional cellular architecture of the nervous system.
Methods
Methods were adapted as previously described (Stamatakis et al., 2013). Briefly, Vgat-ires-
Cre: (Slc32a1tm2(cre)Lowl/J, Jackson Laboratory stock number: 016962, Dat-ires-Cre: 
(B6.SJL-Slc6a3tm1.1(cre)Bkmn/J, Jackson Laboratory stock number: 006660, and TH-ires-
Cre: (B6.129X1-Thtm1(cre)Te/Kieg, European Mouse Mutant Archive stock number: EM:
00254) were used. Mice were injected bilaterally with AAV-DIO-ChR2-eYFP, (AAV5 
~1012 infectious units/mL, packaged and titered by the UNC Vector Core Facility).
Immunohistochemistry
Mice were anesthetized with pentobarbital, and transcardially perfused with PBS followed 
by 4% (w/v) paraformaldehyde in PBS. Brains were then removed and submerged for 24 hr 
in 4% paraformaldehyde and transferred to 30% sucrose in ddH2O for 48hr. 40 um brain 
slices were obtained and subjected to immunohistochemical staining for neuronal cell bodies 
(NeuroTrace Invitrogen; 435-nm excitation/455-nm emission), and/or tyrosine hydoylase 
(Pel Freeze; made in sheep, 1:500). Brain sections were mounted, and z-stack and tiled 
images were captured on a Zeiss LSM 710 confocal microscope using a 20× or 63× 
objective. For fluorescent intensity analysis, images were acquired using identical pinhole, 
gain, and laser settings for all brain regions.
In situ hybridization
A 950 bp riboprobe complimentary to GAD67 sense cDNA was inserted into the pcrII-
TOPO vector (Life Technologies, Carlsbad, CA). Plasmid DNA was cut with either EcoRV 
or Asp718 in order to create template for in vitro transcription. All probes were created 
using Fluorescein-labeled nucleotides. The EcoRV template was transcribed with Sp6 RNA 
Polymerase to generate the sense riboprobe and the Asp718 template was transcribed with 
T7 RNA polymerase to generate the antisense riboprobe. For detection of TH expression, we 
used a 1000 bp riboprobe complimentary to tyrosine hydroxylase sense cDNA that was 
inserted into the pGEM-4Z vector (Promega, Madison, WI). Plasmid DNA was cut with 
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either EcoRI or HindIII in order to create template for in vitro transcription. All probes were 
created using DIG-labeled nucleotides. The HindIII template was transcribed with Sp6 RNA 
Polymerase to generate the sense riboprobe and the EcoRI template was transcribed with T7 
RNA polymerase to generate the antisense riboprobe.
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Figure 1. Differences in TH immunofluoresence intesity across the medial-lateral VTA axis
(A) Confocal image of medial TH+ neurons with optimal gain (B) Confocal image of lateral 
TH+ neurons with gain optomized for the medial portion. Note that most neurons are 
oversaturated. (C) Confocal image of medial VTA TH+ neurons with gain optimized for 
lateral VTA TH+ neurons. Note that neurons that were previously visible (A, white arrows) 
are now difficult to discern. (D) Confocal image of lateral TH+ neurons with gain optimized 
for lateral portion.
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Figure 2. DAT-Cre, TH-Cre, and VGat-Cre targeted neurons project to the LHb
Confocal image of a coronal LHb section (~1.7 posterior) showing expression of ChR2-
eYFP fibers in the LHb following injection of cre-inducible ChR2-eYFP into the VTA of a 
DAT-Cre mouse (A), TH-Cre mouse (B), and VGat-Cre mouse (C). Scale bar = 200 µm.
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Figure 3. Dual fluorescent in situ hybridization for TH and GAD67 in the VTA
(A,B) Confocal image of the anterior medial VTA (~2.8 posterior) from a wild type mouse 
showing appreciable co-localization between TH mRNA (green) and GAD67 mRNA (red). 
Overlap = 32/191 neurons (16.7%). Scale bar (A) = 200 µm. Scale bar (B) = 50 µm. (C,D) 
Confocal image of the posterior lateral VTA (~3.2 posterior) from a wild type mouse 
showing minimal co-localization between TH mRNA and GAD67 mRNA. Overlap = 1/263 
neurons (0.38%) Scale bar (C) = 200 µm. Scale bar (D) = 50 µm.
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